Late gadolinium enhancement (LGE) in CMR is associated with ICI-related myocarditis (OR 4.35) but shows limited sensitivity (62%) and specificity (64%) for diagnosis.
Do cardiac magnetic resonance imaging parameters, including late gadolinium enhancement, predict the diagnosis or prognosis of myocarditis from immune checkpoint inhibitor therapy in adult patients?
While late gadolinium enhancement on CMR is significantly associated with ICI-related myocarditis, its low sensitivity and specificity necessitate a multimodal approach for reliable diagnosis and prognostic assessment.
Absolute Event Rate: 0% vs 0%
Abstract Background and aims Myocarditis from immune checkpoint inhibitor (ICI) therapy is a challenge in clinical practice, and the assessment of ICI-related myocarditis (ICI-M) is often complicated by a variable phenotype. Cardiac magnetic resonance imaging (CMR) is used frequently, but evidence on CMR-based parameters for reliant diagnosis or prognostic assessment of patients with ICI-M is conflicting. This meta-analysis aims to determine whether CMR-derived parameters including late gadolinium enhancement (LGE) are suitable as independent parameters to predict ICI-M diagnosis or prognosis. Methods Scientific databases were searched for studies that assessed CMR parameters in adult patients with suspected myocarditis from immune checkpoint inhibitor therapy (ICI-M). Data from 8 trials with 661 patients were included. Results In this meta-analysis, the mean age of included patients was 64 years, 28% were female patients and 475 patients had ICI-M as per final diagnosis. LGE in CMR was associated with myocarditis following immune checkpoint inhibitor therapy odds ratio (OR) 4.35, 95% confidence interval (CI) 1.59-11.91; n = 601; p=0.004. The most common LGE pattern observed were mid-myocardial (43%) and sub-epicardial (38%) distributions. Myo- or pericardial oedema, despite being associated with vial-induced myocarditis, could not be associated as modality for reliant ICI-M diagnosis OR 0.18, 95% CI 0.07-0.43; n = 433; p=0.06. Further, the available evidence did not consistently indicate pericardial effusion as independent CMR-associated marker for diagnosis of ICI-M OR 1.19, 95% CI 0.03-47.23; n = 315; p=0.93. Presence of LGE showed a trend for prediction of major adverse cardiovascular events (MACE), but failed to statistical significance OR 2.86, 95% CI 0.87-9.40; n = 225; p=0.08. Despite a robust association, sensitivity and specificity of LGE for the diagnosis of ICI-M were only 62% and 64% respectively. Conclusion The diagnostic assessment of ICI-M is challenged by low sensitivity of CMR, often requiring a multimodal approach. Presence of LGE in CMR was associated with ICI-M, but sensitivity and specificity are low. These data indicate that a multimodal diagnostic approach is required for diagnosis and prognostic assessment of ICI-M.
Lerchner et al. (Sat,) reported a other. Late gadolinium enhancement (LGE) in CMR is associated with ICI-related myocarditis (OR 4.35) but shows limited sensitivity (62%) and specificity (64%) for diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: